13G Filing: Camber Capital Management and Amag Pharmaceuticals Inc. (AMAG)

Page 4 of 6 – SEC Filing

13G

CUSIP No.
00163U106
Page 4 of
6
 
 
 
ITEM 1.
(a) Name of
Issuer:
AMAG
Pharmaceuticals, Inc.
 
(b) Address of
Issuer’s Principal Executive Offices:
1100
Winter Street
, Waltham, MA 02451
 
ITEM 2.
(a) Name of Person
Filing:
Camber Capital
Management LLC
Stephen
DuBois
 
(b) Address of
Principal Business Office, or if None, Residence:
Camber Capital
Management LLC
Stephen
DuBois
101 Huntington
Avenue
Suite
2101
Boston, MA
02199
 
(c)
Citizenship:
Camber Capital
Management LLC

Massachusetts
Stephen
DuBois
– United
States
 
(d) Title of Class
of Securities:
Common Stock, par
value $0.01 per share
 
(e) CUSIP
Number:
00163U106
 
 
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO
SS.240.13d-1(b) OR 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON
FILING IS A:
 
 
(a)
[_]
Broker or dealer
registered under Section 15 of the Act  (15 U.S.C.
78o).
 
(b)
[_]
Bank as defined in
Section 3(a)(6) of the Act (15 U.S.C. 78c).
 
(c)
[_]
Insurance company
as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
 
(d)
[_]
Investment company
registered under Section 8 of the Investment Company Act of 1940
(15 U.S.C. 80a-8).
 
(e)
[_]
An investment
adviser in accordance with  ss.240.13d-1(b)(1)(ii)(E);
 
(f)
[_]
An employee benefit
plan or endowment fund in accordance with
ss.240.13d-1(b)(1)(ii)(F);   
 
(g)
[_]
A parent holding
company or control person in accordance with
ss.240.13d-1(b)(1)(ii)(G);   
 
(h)
[_]
A savings
associations as defined in Section 3(b) of the Federal Deposit
Insurance Act (12 U.S.C. 1813);   
 
(i)
[_]
A church plan that
is excluded from the definition of an investment company under
section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C.
80a-3);   
 
(j)
[_]
Group, in
accordance with ss.240.13d-1(b)(1)(ii)(J).
 
ITEM 4. OWNERSHIP.
 
Provide the
following information regarding the aggregate number and percentage
of the class of securities of the issuer identified in Item
1.
 
(a) Amount
beneficially owned: Camber Capital Management LLC –

2,500,000
shares
Stephen DuBois
2,500,000
shares
 
(b) Percent of
class: Camber Capital Management LLC –
7.13% 
Stephen DuBois
– 7.13%
 
 

Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)